Package Leaflet: Information for the User
Donepezilo Normon 5 mg Film-Coated Tablets EFG
Donepezilo, hydrochloride
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Donepezilo belongs to a group of medicines called cholinesterase inhibitors. Donepezilo increases the levels in the brain of a substance related to memory (acetylcholine), by reducing the rate of breakdown of this substance.
It is used for the treatment of mild to moderately severe symptoms of Alzheimer's disease. Symptoms include increased memory loss, confusion, and changes in behavior.
Do not take Donepezilo Normon
Warnings and precautions
Consult your doctor or pharmacist before starting to take Donepezilo Normon if you have or have had:
You should avoid taking donepezilo with other acetylcholinesterase inhibitors and other cholinergic agonists or antagonists.
Donepezilo Normon intake with other medications
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medication, and especially if you are taking any of the following medications:
In case of surgical intervention with general anesthesia, you should inform your doctor and anesthesiologist that you are taking donepezilo as this may affect the amount of anesthetic needed.
Donepezilo may be used in patients with renal or mild to moderate liver disease. Inform your doctor if you have kidney or liver disease. Patients with severe liver disease should not take donepezilo.
Donepezilo Normon intake with food, drinks and alcohol
Donepezilo Normon should be taken with a little water.
You should not take alcohol during treatment with donepezilo as alcohol may reduce its effectiveness.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, or think you may be pregnant or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Do not take donepezilo if you are pregnant or think you may be pregnant.
Do not take donepezilo if you are breastfeeding your child.
Driving and operating machinery
Your condition may affect your ability to drive or operate machinery and you should not do so unless your doctor tells you it is safe to do so. Donepezilo may cause fatigue, dizziness, drowsiness and muscle cramps mainly at the start of treatment or when increasing the dose. If you experience these effects, you should not drive or operate machinery
Donepezilo Normon contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medication.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Donepezilo is administered orally.
Treatment with donepezilo starts with a 5 mg tablet, taken once a day with a little water, at night immediately before going to bed.
After a month of treatment, your doctor may recommend an increase in the dose to 10 mg, taken once a day and at night. The maximum recommended dose is 10 mg per day.
If you have abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend that you take Donepezilo Normon in the morning.
If you have mild or moderate liver disease (a disease that affects the liver) or kidney disease (a disease that affects the kidneys), you can take donepezilo. Inform your doctor before starting treatment if you have liver or kidney problems. Patients with severe liver disease should not take donepezilo.
Use in children
Donepezilo is not recommended for use in children.
If you take more Donepezilo Normon than you should
If you have taken more donepezilo than you should, consult your doctor, pharmacist, or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount used.
The symptoms of overdose may include feeling or being sick, drooling, sweating, decreased heart rate, low blood pressure (dizziness or lightheadedness when standing up), breathing problems, loss of consciousness, and seizures or convulsions.
If you forgot to take Donepezilo Normon
Do not take a double dose to make up for the missed dose.
If you interrupt treatment with Donepezilo Normon
Do not stop treatment with donepezilo unless your doctor tells you to. If you stop taking donepezilo, the benefits of treatment will gradually disappear.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicinecan cause side effects, although not everyone will experience them.
The following side effects have been reported by people taking donepezil. Contact your doctor if you experience any of these side effects during treatment with donepezil.
Severe side effects:
You should inform your doctor immediately if you notice any of the following severe side effects mentioned, as you may need urgent medical treatment.
• Liver damage, for example, hepatitis. The symptoms of hepatitis are feeling or being sick, loss of appetite, general discomfort, fever, itching, yellowing of the skin and eyes, and dark-colored urine (affecting between 1 and 10 out of 10,000 people).
• Ulcers in the stomach or duodenum. The symptoms of ulcers are stomach pain and discomfort (indigestion) between the navel and the breastbone (affecting between 1 and 10 out of 1,000 people).
• Bleeding in the stomach or intestine. This can cause you to have black, tar-like stools or visible blood from the rectum (affecting between 1 and 10 out of 1,000 people).
• Seizures (attacks) or convulsions (affecting between 1 and 10 out of 1,000 people).
• Fever with muscle stiffness, sweating, or decreased level of consciousness (a condition called "Neuroleptic Malignant Syndrome"). (Affects fewer than 1 out of 10,000 people).
• Weakness, sensitivity, or muscle pain, particularly if you also feel unwell, have a fever, or have dark-colored urine. This can be due to abnormal muscle destruction that can be fatal and cause kidney problems (a disease called rhabdomyolysis).
The estimated frequency of side effects is as follows:
Common: may affect more than 1 in 10 patients
Frequent: may affect between 1 and 10 out of 100 patients
Uncommon: may affect between 1 and 10 out of 1,000 patients
Rare: may affect between 1 and 10 out of 10,000 patients
Frequency unknown: cannot be estimated from available data
Reporting side effects
If you experience any type of side effects, consult your doctor or pharmacist, even if it is a side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash.Deposit the packaging and medications you no longer need at the SIGRE collection pointof the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Donepezilo Normon
The active ingredient is hydrochloride of donepezilo. Each tablet contains 5 mg of hydrochloride of donepezilo equivalent to 4.56 mg of donepezilo. The other components are: Nucleus of the tablet: Lactose monohydrate , cornstarch, hydroxypropylcellulose, microcrystalline cellulose, magnesium stearate. Coating: Hypromellose (E464), titanium dioxide (E171), propylene glycol, talc .
Appearance of the product and contents of the packaging
Coated tablets white, round, with a diameter of approximately 7.5 mm.
The formats are as follows: 14, 28, 42, 56, 84, 98, 112 tablets.
Holder of the marketing authorization and responsible for manufacturing
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)
Date of the last review of this leaflet: October 2022
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/ .
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.